Ameritas Investment Partners’s Definium Therapeutics DFTX Stock Holding History

Ameritas Investment Partners’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Buy	11,736 +4,095	+54%	+$101K	0.01%	867
2026 Q1	$144K	Hold	7,641	–	–	﹤0.01%	1458
2025 Q4	$102K	Buy	7,641 +588	+8%	+$7.28K	﹤0.01%	1683
2025 Q3	$83.2K	Hold	7,053	–	–	﹤0.01%	1797
2025 Q2	$45.8K	Hold	7,053	–	–	﹤0.01%	2242
2025 Q1	$41.3K	Hold	7,053	–	–	﹤0.01%	2219
2024 Q4	$49.1K	Hold	7,053	–	–	﹤0.01%	2194
2024 Q3	$40.1K	Hold	7,053	–	–	﹤0.01%	2320
2024 Q2	$50.9K	Buy	+7,053	New	+$61.7K	﹤0.01%	2137
2022 Q2	–	Sell	-1,684	Closed	-$28K	–	3172
2022 Q1	$28K	Hold	1,684	–	–	﹤0.01%	2401
2021 Q4	$35K	Hold	1,684	–	–	﹤0.01%	2351
2021 Q3	$59K	Hold	1,684	–	–	﹤0.01%	2047
2021 Q2	$87K	Buy	+1,684	New	+$88.4K	﹤0.01%	1816

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ameritas Investment Partners's DFTX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Definium Therapeutics (DFTX) stake by 54% in Q2 2026, buying an estimated $101K and bringing the position to 11,736 shares worth $552K. The position accounts for 0.01% of the portfolio, ranked #867.

Ameritas Investment Partners first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Ameritas Investment Partners held 11,736 shares of Definium Therapeutics worth $552K as of Q2 2026.
Ameritas Investment Partners bought 4,095 Definium Therapeutics shares in Q2 2026, an estimated $101K.
Definium Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #867 holding.
Ameritas Investment Partners first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.